Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

The first overall survival data from the Phase 3 CheckMate -067 clinical trial

worldpharmanewsApril 05, 2017

Tag: BMS , monotherapy

PharmaSources Customer Service